Aveanna Healthcare Holdings Inc. (AVAH) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $6.63. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of AVAH = $1.35 (-79.6% from the current price, the stock appears overvalued). Analyst consensus target is AVAH = $11 (+69.7% upside).
Valuation: AVAH trades at a trailing Price-to-Earnings (P/E) of 6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.53.
Financials: revenue is $2.4B, +11%/yr average growth. Net income is $225M, growing at +776.9%/yr. Net profit margin is 9.2% (thin). Gross margin is 33.1% (+2.2 pp trend).
Balance sheet: total debt is $1.3B against $194M equity (Debt-to-Equity (D/E) ratio 6.91, leveraged). Current ratio is 1.32 (adequate). Debt-to-assets is 66.3%. Total assets: $2.0B.
Analyst outlook: 5 / 12 analysts rate AVAH as buy (42%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 90/100 (Pass), Past 25/100 (Fail), Health 17/100 (Fail), Moat 60/100 (Partial), Future 52/100 (Partial), Income 45/100 (Partial).
